Emerging evidence implicates palmitoylation in regulating nutrient transporters (e.g., GLUT1) and metabolic enzymes (e.g., ACLY), suggesting its potential role in rewiring glioma metabolism—a dimension meriting dedicated metabolomic studies. Here, SLC2A1 is linked to glioma.